Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma.

Tadashi KegasawaRyotaro SakamoriKazuki MaesakaRyoko YamadaYuki TahataAyako UrabeTakahiro KodamaHayato HikitaKazuho ImanakaKazuyoshi OhkawaNaoki HiramatsuMasahide OshitaYukinori YamadaMasami InadaTakayuki YakushijinYasuharu ImaiTomohide TatsumiTetsuo Takehara

Published in: Digestive diseases and sciences (2020)

Serum sodium levels are associated with the effectiveness of sorafenib. The serum sodium level can predict the therapeutic effect of sorafenib in advanced HCC patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
randomized controlled trial
chronic kidney disease
systematic review
peritoneal dialysis